Published in Vaccine Weekly, July 24th, 2002
Two-thirds of all people living with HIV are in Africa. African vaccine research currently receives only $41 million of the $2.5 billion - that is, 1.6% - spent on HIV research annually.
Although more than 30 HIV vaccine trials have been conducted globally since 1987, only two of these were carried out in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly